Press Release Service
CRISPR QC Announces Formation of Scientific...
Apr. 11, 2023
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
CRISPR QC
Main focus: CRISPR gene-editing quality control
Company stage: Pre-clinical
Diseases (gene editing): Sickle-cell disease, genetic blindness, amyloidosis (ATTR), type I diabetes
Genome editing tool: CRISPR/Cas9
Funding stage: Private
Location: San Diego, California, USA
Website: https://www.crisprqc.com/?hsLang=en
CRISPR QC provides unique insights on CRISPR mechanics (i.e. cleavage activity, gRNA binding, complex stability), allowing therapeutic companies to optimize gene-editing outcomes.
